Information
-
Trademark
-
79008059
-
Serial Number
79008059
-
Registration Number
3154206
-
International Classifications
-
Filing Date
September 13, 2004
20 years ago
-
Registration Date
October 10, 2006
18 years ago
-
Transaction Date
November 29, 2021
2 years ago
-
Status Date
May 12, 2021
3 years ago
-
Published for Opposition Date
January 24, 2006
18 years ago
-
Location Date
October 10, 2006
18 years ago
-
Status Code
404
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
BENMAMAN, ALICE MEDINA
-
Law Office Assigned Location Code
M70
-
Owners
Mark Drawing Code
4000
Mark Identification
SANOVEL
Case File Statements
- GS0051: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, SKELETO-MUSCULAR DISORDERS, GENERAL INFECTIONS, VIRAL INFECTIONS, CENTRAL NERVOUS SYSTEM DISORDERS, GASTRO-INTESTINAL DISORDERS, FUNGAL DISEASES, ERECTILE DYSFUNCTION, RESPIRATORY DISEASES, ALLERGY, OPHTHALMIC DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS - CROMOLIN SODIUM, AMLODIPIN BESYLATE, ALENDRONATE SODIUM, CHLORAZEPATE DIPOTASSIUM, ATROPINE SULPHATE, ATORVASTATIN CALCIUM, CANDESARTAN CILEXETIL, CEFTRIAXONE SODIUM, EPHEDRINE HCL, GUAIPHENESINE, ZAFIRLUKAST, DONEPEZIL HCL, DIFLUNISAL, DIPYRIDAMOLE, FAMOTIDINE, LOSARTAN POTASSIUM, HYDRO-CHLOROTHIAZIDE, MELOXICAM, PHENYLEPRINE HCL, FEXOFENADINE HCL, INDAPAMIDE, SULFISOXAZOLE, CLOPIDOGREL, LANSOPRAZOLE, CLARITHROMYCIN, FLURBIPROFEN, NIMESULIDE, PANTOPRAZOLE, PARACETAMOLE, PILOCARPINE HCL, LISINOPRIL, PSEUDOEPHEDRINE HCL, CIPROFLOXACIN HCL, SERTRALINE HCL, CYCLOPENTOLATE HCL, DIHYDROERGOTOXINE METHANSULFONATE, TERBINAFINE, TIMOLOL MALEATE, TIAMPHENICOL, AZITHROMYCIN, TENOXICAM, FLUCONAZOLE, DIGOXINE, TIOCONAZOLE, DIMENHYDRINATE, QUINIDINE ARABOGALACTANE SULPHATE, QUINIDINE PHENYLETHYL BARBITURATE, DILTIAZEM HCL, BUSPIRONE HCL, AMIODARONE HCL, TRAZODONE, DIFLUPREDNATE, ENOXACIN, LACTULOSE, KETOROLAC, PENTOXIFYLLINE, VITAMIN E, CHLORHEXIDINE, CETRIMIDE, PROPYPHENAZONE, CAFFEINE, CETIRIZINE, PHENYLPROPANOLAMINE, ZOLPIDEM, BACAMPICILLIN HCL, ROXITHROMYCIN, SULTAMICILLIN TOSILATE, ACETYLSALICYLIC ACID, AMPICILLIN NA, SULBACTAM NA, SILDENAFIL CITRATE, AMBROXOL HCL, RIBAVIRIN, LORATADINE, ETODOLAC, OMEPRAZOLE, OXYBUTYNIN CHLORIDE, QUINIDINE SULPHATE, OLANZAPINE, RALOXIFEN, PIOGLITAZONE, MOXIFLOXACIN, ROSIGLITAZONE, SIBUTRAMIN, CARVEDILOL, MONTELUKAST, CITALOPRAM, GLICLAZIDE, CEFACLOR, EZETIMIBE, ROFECOXIB, QUETIAPINE FUMARATE, METFORMIN HCL, ACARBOSE, CHLORPHENIRAMINE MALEATE, NATEGLINIDE, LEFLUNOMIDE, VALSARTAN, CEFAZOLIN SODIUM, DIACEREIN, PAROXETINE, LEVOFLOXACIN, LEVETIRACETAM, ZOLMITRIPTAN, GLIBENCLAMIDE, TIZANIDINE, PERINDOPRIL ERBUMINE, RAMIPRIL, CEFTAZIDIME, CEFUROXIME AXETYL, THIOCOLCHICOSIDE, ACAMPROSATE, ACETYLCYSTEINE, ALPHA CALCIDOL, ALPHA LIPOIC ACID, ARIPIPRAZOLE, ATOMOXETINE, BALSALAZIDE DISODIUM, BUTENAFINE HCL, CALCITRIOL, CARBONYL IRON, FOLIC ACID, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, CEFDINIR, CEFEPIME HCL, CEFIXIME, CEFPODOXIME PROXETIL, CEFPROZIL, CEPHALEXINE MONOHYDRATE, CICLESONIDE, CILAZAPRIL, CILOSTAZOL, CINITAPRIDE, CITICOLINE, CO-ENZYME Q10, DARIFENASIN, DEFERIPRONE, DOTHIEPIN, DULOXETINE, ELETRIPTAN, ESCITALOPRAM, ESOMEPRAZOLE, ETORICOXIB, FELODIPINE, FENOFIBRATE, FERROUS SULPHATE, ZINC SULPHATE, FLUVASTATIN, FROVATRIPTAN, GABAPENTIN, GALANTAMINE, GEMIFLOXACIN, GINKGO BILOBA, GLIMEPRIDE, GRANISETRON, IBANDRONATE, IRBESARTAN, IRON HYDROXIDE POLYMALTOSE, LAMIVUDINE, LAMOTRIGINE, LEVETIRACETAM, LETROZOLE, LINEZOLIDE, MEMANTINE HCL, METOPROLOL, MIDODRINE, MIRTAZAPINE, MIZOLASTINE, MOSAPRIDE CITRATE DIHYDRATE, MYCOPHENOLATE MOFETIL, NEBIVOLOL, NEFAZODONE, NIACIN, NITAZOXANIDE, ONDANSETRON, ORNIDAZOLE, OXCARBAZEPINE, PIMECROLIMUS, PRAVASTATIN, PREGABALIN, RABEPRAZOL, REBAMIPIDE, REPAGLINIDE, RISEDRONATE, RISPERIDONE, RIVASTIGMINE, ROSUVASTATIN, SACCHAROMYCES BOULARDII, TACROLIMUS, TADALAFIL, TAMSULOSIN HCL, TAZAROTEN, TAZOBACTAM SODIUM, PIPERACILLIN SODIUM, TEGASEROD, TELITHROMYCIN, TERAZOCIN, TERIPARATIDE, TOLTERODINE TARTRATE, TOPIRAMATE, TRANDOLAPRIL, TRIMETHAZIDINE, VALACYCLOVIR, VALPROATE SODIUM, VENLAFAXINE, VORICONAZOLE, XIMELAGATRAN, ZALEPLON, ZIPRASIDONE, ZOLEDRONIC ACID
Case File Event Statements
-
11/28/2021 - 2 years ago
35 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Type: DENC
-
11/28/2021 - 2 years ago
34 - DEATH OF INTERNATIONAL REGISTRATION
Type: DETH
-
1/25/2018 - 6 years ago
33 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
6/1/2015 - 9 years ago
32 - TOTAL INVALIDATION PROCESSED BY THE IB
Type: INNT
-
8/27/2014 - 10 years ago
31 - GENERIC MADRID TRANSACTION SENT TO IB
Type: XXSS
-
8/27/2014 - 10 years ago
30 - GENERIC MADRID TRANSACTION CREATED
Type: XXCR
-
5/13/2014 - 10 years ago
29 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Type: INTR
-
9/13/2013 - 11 years ago
28 - CANCELLED SECTION 71
Type: C71T
-
11/3/2012 - 12 years ago
27 - CHANGE OF NAME/ADDRESS REC'D FROM IB
Type: ADCH
-
6/2/2011 - 13 years ago
26 - INTERNATIONAL REGISTRATION RENEWED
Type: RNWL
-
6/5/2008 - 16 years ago
25 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
5/7/2007 - 17 years ago
24 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
5/7/2007 - 17 years ago
23 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
5/7/2007 - 17 years ago
22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
10/10/2006 - 18 years ago
21 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
8/3/2006 - 18 years ago
20 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Type: OPNX
-
7/20/2006 - 18 years ago
19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
7/20/2006 - 18 years ago
18 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Type: OPNR
-
7/14/2006 - 18 years ago
17 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
6/9/2006 - 18 years ago
16 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Type: ETOP
-
2/21/2006 - 18 years ago
15 - EXTENSION OF TIME TO OPPOSE RECEIVED
Type: ETOF
-
1/24/2006 - 18 years ago
14 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
1/4/2006 - 18 years ago
13 - NOTICE OF PUBLICATION
Type: NPUB
-
12/7/2005 - 18 years ago
12 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
12/2/2005 - 18 years ago
11 - ASSIGNED TO LIE
Type: ALIE
-
11/28/2005 - 18 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
10/27/2005 - 19 years ago
9 - AMENDMENT FROM APPLICANT ENTERED
Type: ACEC
-
10/14/2005 - 19 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
10/14/2005 - 19 years ago
7 - PAPER RECEIVED
Type: MAIL
-
6/20/2005 - 19 years ago
6 - REFUSAL PROCESSED BY IB
Type: RFNT
-
4/14/2005 - 19 years ago
5 - NON-FINAL ACTION MAILED
Type: CNRT
-
4/11/2005 - 19 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/11/2005 - 19 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/18/2005 - 19 years ago
2 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP
-
2/17/2005 - 19 years ago
1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Type: SDRC